AcureOmics AB granted millions by EU
AcureOmics, part of Umeå Biotech Incubator (UBI), is based on leading research conducted at Umeå University, the Swedish University of Agricultural Sciences (SLU) and Uppsala University. In close collaboration with clinical researchers and molecular biologists AcureOmics will enhance the possibilities of finding slinks between genotype and changes in the metabolic profile.
- Of course it is a great pleasure for us as researchers to have the possibility to develop our research results in order to create benefit for patients, says docent Johan Trygg, senior lecturer at the institution of chemistry, Umeå University.
www.kbc.umu.se/clic), an interdisciplinary centre in chemometrics and bioinformatics at the university centre for Chemistry and Biology (KBC). He is a pioneer in multivariate data analysis, methods necessary for extracting information from the large and complex data sets that created.
AcureOmics AB is devoted to personalized medicine, systems biology including the “omics” fields of research and the areas of biofluid profiling. ”Omics” is a collective term for research in the fields of genomics, proteomics and metabolomics. Services are provided in analysis of collected samples using NMR, MS and/or other techniques needed as well as multivariate data analysis of the complex data structures that result from such studies. AcureOmics is a company with unique competence in the “omics” field of data analysis and interpretation.
Jon Gabrielsson, CEO, AcureOmics AB
Mobil: +46 (0)70 699 59 98
Mobil: +46 (0)73 064 71 37
Mobil: +46 (0)70 269 06 84